Roth Affirms TG Therapeutics (TGTX) at 'Focus Pick'; Sees Strong Results in 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2015 Financial Results and Business Update
March 7, 2016 4:00 PM ESTEnded 2015 in a Strong Financial Position, With More Than $100 Million in Cash and Investments
Investor Conference Call to be Held Today, Monday, March 7, 2016 at 4:30pm ET Â
NEW YORK, March 07, 2016 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the fourth quarter and year ended December 31, 2015 and provided recent company developments along with a business outlook for 2016.
Michael S. Weiss, the Company's Executive Chairman and Interim Chief Executive Officer, stated, "2015 was a transformational year for our Company as we launched our first registration... More
TG Therapeutics, Inc. to Present at Upcoming Investment Conferences
March 7, 2016 7:30 AM ESTNEW YORK, March 07, 2016 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq: TGTX) today announced its participation at two upcoming investment conferences. Michael S. Weiss, the Companys Executive Chairman and Interim Chief Executive Officer, is scheduled to present tomorrow Tuesday, March 8, 2016 at 11:35am ET, at the Raymond James & Associates 37th Annual Institutional Investors Conference, being held at the JW Marriott Grande Lakes in Orlando, Florida. Â Michael... More
TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2015 Financial Results and Business Update
March 4, 2016 7:30 AM ESTNEW YORK, March 04, 2016 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held on Monday, March 7, 2016 at 4:30pm ET to discuss results for the fourth quarter and year-end 2015, and provide a business outlook for 2016. Â Michael S. Weiss, Executive Chairman and Interim Chief Executive Officer, will host the call.
In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029... More
